Alzheimer's Drug Discovery

New York, United States Founded: 1998 • Age: 28 yrs
Drugs for Alzheimers prevention, treatment, and cure are discovered.

About Alzheimer's Drug Discovery

Alzheimer's Drug Discovery is a company based in New York (United States) founded in 1998 by Ronald S Lauder and Leonard A Lauder.. Alzheimer's Drug Discovery offers products and services including Research Funding and Diagnostics Accelerator.

  • Headquarter New York, United States
  • Founders Ronald S Lauder, Leonard A Lauder
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name The Alzheimer's Drug Discovery Foundation
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $75 K (USD), Grant

    Sep 23, 2010

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alzheimer's Drug Discovery

Alzheimer's Drug Discovery offers a comprehensive portfolio of products and services, including Research Funding and Diagnostics Accelerator. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Funding is provided for Alzheimer's research projects to advance drug discovery and prevention efforts

Acceleration of diagnostics for Alzheimer's disease is facilitated through targeted programs and partnerships

Funding Insights of Alzheimer's Drug Discovery

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $75,000
  • First Round

    (15 Sep 2007)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2010 Amount Grant - Alzheimer's Drug Discovery Valuation

investors

HHS
Sep, 2008 Amount Grant - Alzheimer's Drug Discovery Valuation

investors

HHS
Sep, 2007 Amount Grant - Alzheimer's Drug Discovery Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Alzheimer's Drug Discovery

Alzheimer's Drug Discovery has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Alzheimer's Drug Discovery

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Alzheimers Drug Discovery

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Alzheimer's Drug Discovery Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Alzheimer's Drug Discovery

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Alzheimer's Drug Discovery

Frequently Asked Questions about Alzheimer's Drug Discovery

When was Alzheimer's Drug Discovery founded?

Alzheimer's Drug Discovery was founded in 1998 and raised its 1st funding round 9 years after it was founded.

Where is Alzheimer's Drug Discovery located?

Alzheimer's Drug Discovery is headquartered in New York, United States. It is registered at New York, New York, United States.

Who is the current CEO of Alzheimer's Drug Discovery?

Mark Roithmayr is the current CEO of Alzheimer's Drug Discovery.

What does Alzheimer's Drug Discovery do?

The Alzheimers Drug Discovery Foundation was established in 1998 in New York, United States, within the healthcare and biotechnology sector. Focus is placed on drug discovery efforts aimed at preventing, treating, and curing Alzheimers disease. Early-stage research funding, clinical trial support, and assistance are extended to scientists and institutions. Public resources are made available via the Cognitive Vitality platform, which delivers information on brain health and aging.

What products or services does Alzheimer's Drug Discovery offer?

Alzheimer's Drug Discovery offers Research Funding and Diagnostics Accelerator.

Who are Alzheimer's Drug Discovery's investors?

Alzheimer's Drug Discovery has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available